Dear friends and colleagues.
After nearly three years of intense work, the eTRANSAFE ship is advancing towards its last 24 months at sea. The project has faced and successfully overcome several challenges in this period, to which we can add the recent corona virus pandemic that has shook our lives in these past few months. The global race for COVID-19 treatments and vaccines has reminded us of the importance of investing in robust research and innovation initiatives to achieve better and faster therapies, and it has also proven the necessity of collaborative efforts required between countries and supranational organizations, as well as in the public and private arenas, to reach these common goals.
During this time, the eTRANSAFE consortium has reached its equator at the end of February, which was marked by a successful completion of the Mid-term Review held in Brussels in early March. The reviewers complimented the project progress and the innovations developed and we are proud to record that some of the presented achievements have been recently chosen by the European Commission´s Innovation Radar and included in the EU-funded innovations platform in July.
Two Consortium Meetings have also taken place this year. The 8th CM, centred on the preparation of the Mid-Term review, was organized in Barcelona in late February, gathering the whole consortium to our last face-to-face assembly for the time being. Despite impressive efforts and progress, we also had to learn over the recent months that the integration of the different tools and assets we had developed over the past two and a half year still poses a tremendous challenge if we want to achieve a functional, user-friendly and sustainable Tox-Hub.
While the 9th CM was held in an entirely virtual format in early June, we were successful in analysing the major technical hurdles which might impede integration activities and in devising plans how to overcome them in the next couple of months.
As of summer 2020, roughly two years remain until the project end. The next key step will be the deployment and the testing phase of the first system prototype, which will get us closer to our final objective of supporting and improving drug discovery and development.
We wish you all a great end of summer and beginning of autumn and that you stay connected to the eTRANSAFE news.